Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight

NCT06588296 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

279

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriatic Arthritis
Obesity

Interventions

DRUG: Ixekizumab
DRUG: Tirzepatide

Sponsor

Eli Lilly and Company